D.E. Shaw & Co’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $69.9K | Buy |
+56,808
| New | +$69.9K | ﹤0.01% | 2916 |
|
2024
Q2 | – | Sell |
-592,889
| Closed | -$700K | – | 3297 |
|
2024
Q1 | $700K | Buy |
592,889
+86,001
| +17% | +$101K | ﹤0.01% | 2274 |
|
2023
Q4 | $463K | Buy |
506,888
+235,578
| +87% | +$215K | ﹤0.01% | 2395 |
|
2023
Q3 | $226K | Sell |
271,310
-105,519
| -28% | -$87.9K | ﹤0.01% | 2554 |
|
2023
Q2 | $452K | Buy |
376,829
+240,654
| +177% | +$289K | ﹤0.01% | 2370 |
|
2023
Q1 | $172K | Sell |
136,175
-179,450
| -57% | -$226K | ﹤0.01% | 2834 |
|
2022
Q4 | $685K | Buy |
315,625
+29,867
| +10% | +$64.8K | ﹤0.01% | 2593 |
|
2022
Q3 | $3.42M | Buy |
285,758
+248,010
| +657% | +$2.97M | ﹤0.01% | 1749 |
|
2022
Q2 | $316K | Sell |
37,748
-5,166
| -12% | -$43.2K | ﹤0.01% | 3221 |
|
2022
Q1 | $372K | Buy |
+42,914
| New | +$372K | ﹤0.01% | 3351 |
|